Efficacy and safety of once-weekly insulin icodec versus once-daily insulin degludec in type 1 diabetes: ONWARDS 6

被引:0
|
作者
Russell-Jones, D. [1 ]
Babazono, T. [2 ]
Cailleteau, R. [3 ]
Engberg, S. [3 ]
Irace, C. [4 ]
Kjaersgaard, M. I. S. [5 ]
Mathieu, C. [6 ]
Rosenstock, J. [7 ]
Woo, V. [8 ]
Klonoff, D. C. [9 ]
机构
[1] Univ Surrey, Dept Endocrinol & Diabet, Guildford, Surrey, England
[2] Tokyo Womens Med Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[3] Novo Nordisk AS, Soborg, Denmark
[4] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Viale Europa, Catanzaro, Italy
[5] Novo Nordisk AS, Aalborg, Denmark
[6] Univ Leuven, Clin & Expt Endocrinol, Leuven, Belgium
[7] Velocity Clin Res Med City, Dallas, TX USA
[8] Univ Manitoba, Winnipeg, MB, Canada
[9] Mills Peninsula Med Ctr, Diabet Res Inst, San Mateo, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
9
引用
收藏
页码:S7 / S8
页数:2
相关论文
共 50 条
  • [41] Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes according to Baseline Glucagon-Like Peptide 1 Receptor Agonist Use-ONWARDS 1-5
    Vilsboll, Tina
    Bangsgaard, Katrine O.
    Fu, Ariel
    Kellerer, Monika
    Sogaard, Stinne B.
    Goldenberg, Ronald
    DIABETES, 2024, 73
  • [42] Insulin icodec: A novel once-weekly treatment for diabetes
    Schaffner, Hannah
    Wiener, Jordyn
    Deluca, Amanda
    Genovese, Ariana
    Deeb, Alexander
    Deeb, Wasim
    Sheikh-Ali, Mae
    Sutton, David
    Gore, Ashwini
    Berner, Jason
    Huston, Jessica
    Goldfaden, Rebecca
    DIABETIC MEDICINE, 2024, 41 (10)
  • [43] Efficacy and safety of once-weekly insulin versus once-daily insulin in patients with type 1 and type 2 diabetes mellitus: an updated meta-analysis of randomized controlled trials
    Xue, Mei
    Shen, Pan
    Tang, Jun
    Deng, Xuan
    Dai, Zhe
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [44] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with Type 2 diabetes (SUSTAIN 4)
    Aroda, V. R.
    Bain, S. C.
    Cariou, B.
    Piletic, M.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    de Vries, J. H.
    DIABETIC MEDICINE, 2017, 34 : 146 - 146
  • [45] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    DeVries, J. H.
    Bain, S. C.
    Cariou, B.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    Aroda, V. R.
    DIABETOLOGIA, 2016, 59 : S76 - S77
  • [46] Once-weekly basal insulin icodec offers comparable efficacy and safety vs once-daily insulin glargine U100 in insulin naive patients with type 2 diabetes inadequately controlled on OADs
    Rosenstock, J.
    Kjaersgaard, M.
    Moller, D.
    Hansen, M.
    Goldenberg, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S28 - S29
  • [47] CONTINUOUS GLUCOSE MONITORING IN INSULINEXPERIENCED INDIVIDUALS WITH TYPE 2 DIABETES SWITCHED TO ONCE-WEEKLY INSULIN ICODEC VERSUS ONCE-DAILY COMPARATORS IN ONWARDS 2 AND 4: POST-HOC ANALYSIS
    Bajaj, H.
    Asbjornsdottir, B.
    Lehrskov, L. L.
    Mathieu, C.
    Philis-Tsimikas, A.
    Wang, N.
    Battelino, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A52 - A53
  • [48] Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes
    Hovelmann, Ulrike
    Brondsted, Lise
    Kristensen, Niels R.
    Ribel-Madsen, Rasmus
    Devries, J. Hans
    Heise, Tim
    Haahr, Hanne
    DIABETES, 2020, 69
  • [49] Insulin icodec: an insulin analogue suited for once-weekly dosing in type 2 diabetes
    Hovelmann, U.
    Brondsted, L.
    Kristensen, N. R.
    Ribel-Madsen, R.
    DeVries, J. H.
    Heise, T.
    Haahr, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S316 - S316
  • [50] Once-Weekly Insulin Icodec versus Once-Daily Long-Acting Insulin for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Abuelazm, Mohamed T.
    Elzeftawy, Mohamed A.
    Gowaily, Ibrahim
    Badr, Amr
    Amin, Ahmed Mazen
    Ibrahim, Ahmed A.
    Elsaeidy, Ahmed Saad
    Ali, Shafaqat
    Abdelazeem, Basel
    CIRCULATION, 2023, 148